The Board granted service connection for prostate cancer due to herbicide exposure and for the cause of death, but denied death pension benefits.
The deciding factor: Prostate cancer was presumed related to in-service herbicide exposure based on the Veteran's service at Ubon RTAFB during the applicable timeframe. The immediate cause of death listed on the death certificate was prostate cancer, which was granted as a service-connected disability.
- Claimed conditions
- Prostate cancer
- How they argued it
- Presumptive (no nexus needed)
- Exposure basis
- Agent Orange / herbicides
- Rating assigned
- None in this decision
- Decision date
- October 22, 2024
- Citation
- A24067757
What this means for you
A partial grant means some issues were granted while others were denied or remanded — common in multi-issue claims. Look at which issues went which way, and how each was argued.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Board restored the Veteran's 100 percent disability rating for his service-connected prostate cancer, effective September 1, 2024.
- Partly granted
The Board denied a higher disability rating for PTSD and granted service connection for lumbosacral strain, while denying service connection for prostate cancer, erectile dysfunction, hypertension, and nuclear sclerosis and dry eye syndrome.
- Dismissed
The appeals for service connection and higher initial rating were dismissed due to concurrent election of review options.
- Granted
The Veteran was granted an earlier effective date of August 10, 2022, for the grant of a total disability rating due to individual unemployability (TDIU).
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.